Large Platelets Circulate in an Activated State in Diabetes Mellitus
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is associated with aggravated development of vascular complications. Yet, it has not been established whether platelet hyperreactivity contributes as a pathogenetic factor. In order to study the role of activated platelets in diabetes mellitus, we investigated the expression of the membrane activation markers CD63 (GP53) and CD62 (GMP-140) as direct indicators of in vivo activation. The CD63-positive fraction was significantly higher in patients (6.1% X 3.7 +/- 1) than in controls (2.7% X 3 +/- 1). In parallel, the CD62-positive fraction was significantly elevated in patients to 5% X 2.5 +/- 1 in comparison to controls (3% X 2 +/- 1). Patients with angiopathy had a mean increase of 304% in CD63-positive and of 223% in CD62-positive platelets. Patients without clinically detectable angiopathy showed a trend to an increased fraction in CD63-/CD62-positive platelets. There was no correlation of the activation markers with fasting blood glucose, HbA1 or platelet count. CD63 platelet bound fluorescence significantly increased with platelet size in the patient group. We conclude that in diabetes mellitus an increased number of large platelets circulate in an activated state predominantly in patients with angiopathy. This could imply that platelets become activated by vascular lesions. The trend in patients without vascular disease, however, suggests that activated platelets may also basically contribute to the prethrombotic state in diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased platelet clearance results in a reduced platelet life span and a relative preponderance of large, immature circulating platelets.34,35”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [34]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877 · cited 1×
“10,24-26 it has been speculated that this could be due to the time lag of platelet turnover and megakaryocytic thrombopoiesis and that reversal would require long-term metabolic normalization.(29,30) Our data confirm the fact that glucose metabolism is of minor influence with regard to the platelet activation status.”
BackgroundStenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., & Bainton, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.880 · Cited by 871
Johnston, G. I., Cook, R. G., & McEver, R. P. (1989) · Cell · doi:10.1016/0092-8674(89)90636-3 · Cited by 786 · cited 3×
“Both subcellular antigenic epitopes have been shown to be detectable on the outer platelet membrane only after activation.(15-17,19,20)”
BackgroundShattil, S., Cunningham, M., & Hoxie, J. (1987) · Blood · doi:10.1182/blood.v70.1.307.307 · Cited by 756
Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus
Panzram, G. (1987) · Diabetologia · doi:10.1007/bf00274216 · Cited by 541
Kaplan, K., & Owen, J. (1981) · Blood · doi:10.1182/blood.v57.2.199.199 · Cited by 518
Nieuwenhuis, H., van Oosterhout, J., Rozemuller, E., van Iwaarden, F., & Sixma, J. (1987) · Blood · doi:10.1182/blood.v70.3.838.838 · Cited by 287
Self-citationPlatelet size as a determinant of platelet function.
Thompson, C. B., Jakubowski, J. A., Quinn, P. G., Deykin, D., & VALERI, C. R. (1983) · PubMed · Cited by 234
Diabetes, Intermittent Claudication, and Risk of Cardiovascular Events: The Framingham Study
Brand, F. N., Abbott, R. D., & Kannel, W. B. (1989) · Diabetes · doi:10.2337/diab.38.4.504 · Cited by 234
Studies of human plate alpha-granule release in vivo
Files, J., Malpass, T., Yee, E., Ritchie, J., & Harker, L. (1981) · Blood · doi:10.1182/blood.v58.3.607.607 · Cited by 202
Cited by
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2430 · Cited by 538
“Increased platelet turnover (36), cytosolic levels of calcium (37), oxidative stress resulting in aspirin-insensitive thromboxane biosynthesis (38), altered structure of platelet membrane due to impaired lipid metabolism, and enhanced protein glycation reducing interaction with drug target (39) all affect response to…”
BackgroundPlatelet activation: assessment and quantification
Kamath, S. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2515 · Cited by 516
“Platelet activation seems to be influenced by diabetes mellitus([7]), smoking([8]), hypertension and also the use of oral contraceptives([94]).”
BackgroundFlow cytometry: a clinical test of platelet function
Michelson, A. (1996) · Blood · doi:10.1182/blood.v87.12.4925.bloodjournal87124925 · Cited by 490
The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases
Vizioli, L., Muscari, S., & Muscari, A. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02070.x · Cited by 369
Metadata
- Authors
- Tschoepe, D., Roesen, P., Esser, J., Schwippert, B., Nieuwenhuis, H., Kehrel, B., & Gries, F.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- University of Münster (DE)
- ORCID
- Venue
- Seminars in Thrombosis and Hemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1991-10
- Volume
- 17
- Issue
- 04
- Pages
- 433-438
- ISSN
- 0094-6176 (ISSN-L)
- 1098-9064
- OpenAlex
- W1970616328
- Cited by
- 266
- References
- 23
- Citations by year
- 2025: 2 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 8 · 2018: 3 · 2017: 12 · 2016: 10 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 12
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Thrombosis and Hemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- diabetes mellitus, platelet activation, large platelets, CD63, CD62, P-selectin, diabetic vascular disease, vascular complications, hypercoagulability, platelet size
- MeSH terms
- Adult, Aged, Antibodies, Monoclonal, Diabetes Mellitus, Female, Flow Cytometry, Humans, Male, Middle Aged, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Large Platelets Circulate in an Activated State in Diabetes Mellitus. https://app.cochat.ai/papers/10.1055/s-2007-1002650
- The paper
- Tschoepe, D., Roesen, P., Esser, J., Schwippert, B., Nieuwenhuis, H., Kehrel, B., & Gries, F. (1991). Large Platelets Circulate in an Activated State in Diabetes Mellitus. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-2007-1002650
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.